The University of Chicago Header Logo

Connection

Rita Nanda to Programmed Cell Death 1 Receptor

Back to Details
This is a "connection" page, showing publications Rita Nanda has written about Programmed Cell Death 1 Receptor.
Rita Nanda
Connection Strength
1.387
Programmed Cell Death 1 Receptor
  1. Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial. JAMA Oncol. 2020 05 01; 6(5):676-684.
    View in: PubMed
    Score: 0.669
  2. Immune Checkpoint Blockade for Breast Cancer. Cancer Treat Res. 2018; 173:155-165.
    View in: PubMed
    Score: 0.569
  3. Immune Checkpoint Inhibitor Therapy in Breast Cancer. J Natl Compr Canc Netw. 2018 10; 16(10):1259-1268.
    View in: PubMed
    Score: 0.150
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.